Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

Detrimental Effects of Psychotropic Medications Differ by Sex in Aging People with HIV.

Mathur S, Roberts-Toler C, Tassiopoulos K, Goodkin K, McLaughlin M, Bares S, Koletar SL, Erlandson KM; ACTG A5322 Study Team.

J Acquir Immune Defic Syndr. 2019 May 21. doi: 10.1097/QAI.0000000000002100. [Epub ahead of print]

PMID:
31169770
2.

Depressive Symptomatology, Syndromal Depression, and HIV-Associated Neurocognitive Disorder (HAND).

Goodkin K, Patten SB.

Can J Psychiatry. 2018 May;63(5):284-286. doi: 10.1177/0706743718754537. No abstract available.

3.

End-of-Life Care and Bereavement Issues in Human Immunodeficiency Virus-AIDS.

Goodkin K, Kompella S, Kendell SF.

Nurs Clin North Am. 2018 Mar;53(1):123-135. doi: 10.1016/j.cnur.2017.10.010. Review.

4.

Redefining Aging in HIV Infection Using Phenotypes.

Stoff DM, Goodkin K, Jeste D, Marquine M.

Curr HIV/AIDS Rep. 2017 Oct;14(5):184-199. doi: 10.1007/s11904-017-0364-x. Review.

5.

Effect of ageing on neurocognitive function by stage of HIV infection: evidence from the Multicenter AIDS Cohort Study.

Goodkin K, Miller EN, Cox C, Reynolds S, Becker JT, Martin E, Selnes OA, Ostrow DG, Sacktor NC; Multicenter AIDS Cohort Study.

Lancet HIV. 2017 Sep;4(9):e411-e422. doi: 10.1016/S2352-3018(17)30098-X. Epub 2017 Jul 14.

6.

Diagnostic utility of the HIV dementia scale and the international HIV dementia scale in screening for HIV-associated neurocognitive disorders among Spanish-speaking adults.

López E, Steiner AJ, Smith K, Thaler NS, Hardy DJ, Levine AJ, Al-Kharafi HT, Yamakawa C, Goodkin K.

Appl Neuropsychol Adult. 2017 Nov-Dec;24(6):512-521. doi: 10.1080/23279095.2016.1214835. Epub 2016 Aug 15.

7.

Assessing the prevalence of HIV, HBV, and HCV infection among people with severe mental illness.

Goodkin K.

Lancet Psychiatry. 2016 Jan;3(1):4-6. doi: 10.1016/S2215-0366(15)00569-6. No abstract available. Erratum in: Lancet Psychiatry. 2016 Mar;3(3):199.

8.

Cortical brain atrophy and intra-individual variability in neuropsychological test performance in HIV disease.

Hines LJ, Miller EN, Hinkin CH, Alger JR, Barker P, Goodkin K, Martin EM, Maruca V, Ragin A, Sacktor N, Sanders J, Selnes O, Becker JT; Multicenter AIDS Cohort Study.

Brain Imaging Behav. 2016 Sep;10(3):640-51. doi: 10.1007/s11682-015-9441-1.

9.

Diagnostic Utility of the International HIV Dementia Scale for HIV-Associated Neurocognitive Impairment and Disorder in South Africa.

Goodkin K, Hardy DJ, Singh D, Lopez E.

J Neuropsychiatry Clin Neurosci. 2014 Fall;26(4):352-8. doi: 10.1176/appi.neuropsych.13080178.

10.

Mixed membership trajectory models of cognitive impairment in the multicenter AIDS cohort study.

Molsberry SA, Lecci F, Kingsley L, Junker B, Reynolds S, Goodkin K, Levine AJ, Martin E, Miller EN, Munro CA, Ragin A, Sacktor N, Becker JT.

AIDS. 2015 Mar 27;29(6):713-21. doi: 10.1097/QAD.0000000000000561.

11.

No association between Apoε4 alleles, HIV infection, age, neuropsychological outcome, or death.

Becker JT, Martinson JJ, Penugonda S, Kingsley L, Molsberry S, Reynolds S, Aronow A, Goodkin K, Levine A, Martin E, Miller EN, Munro CA, Ragin A, Sacktor N.

J Neurovirol. 2015 Feb;21(1):24-31. doi: 10.1007/s13365-014-0290-2. Epub 2014 Nov 12.

12.

Clinical utility of magnetic resonance spectroscopy to enhance diagnosis of HIV-associated mild neurocognitive disorder.

Goodkin K, Alger JR, Maudsley AA, Govind V, Sheriff S, Zhang JM.

Neuropsychiatry (London). 2012 Oct 1;2(5):379-383. No abstract available.

13.

A perspective on the proposal for neurocognitive disorder criteria in DSM-5 as applied to HIV-associated neurocognitive disorders.

Goodkin K, Fernandez F, Forstein M, Miller EN, Becker JT, Douaihy A, Cubano L, Santos FH, Filho NS, Zirulnik J, Singh D.

Neuropsychiatry (London). 2011 Oct 1;1(5):431-440.

14.

Factors affecting brain structure in men with HIV disease in the post-HAART era.

Becker JT, Maruca V, Kingsley LA, Sanders JM, Alger JR, Barker PB, Goodkin K, Martin E, Miller EN, Ragin A, Sacktor N, Selnes O; Multicenter AIDS Cohort Study.

Neuroradiology. 2012 Feb;54(2):113-21. doi: 10.1007/s00234-011-0854-2. Epub 2011 Mar 22.

15.

A proposition against using the terms "Hispanic" and "Latino" in research on HIV-associated neurocognitive disorders.

López E, Morales G, Saucedo C, Aguirre-Girón L, Mack S, Goodkin K.

Ethn Dis. 2010 Autumn;20(4):479-84.

PMID:
21305841
16.

Subcortical brain atrophy persists even in HAART-regulated HIV disease.

Becker JT, Sanders J, Madsen SK, Ragin A, Kingsley L, Maruca V, Cohen B, Goodkin K, Martin E, Miller EN, Sacktor N, Alger JR, Barker PB, Saharan P, Carmichael OT, Thompson PM; Multicenter AIDS Cohort Study.

Brain Imaging Behav. 2011 Jun;5(2):77-85. doi: 10.1007/s11682-011-9113-8.

17.

Increasing response diversity in children with autism.

Napolitano DA, Smith T, Zarcone JR, Goodkin K, McAdam DB.

J Appl Behav Anal. 2010 Summer;43(2):265-71. doi: 10.1901/jaba.2010.43-265.

18.

Normative scores for a brief neuropsychological battery for the detection of HIV-associated neurocognitive disorder (HAND) among South Africans.

Singh D, Joska JA, Goodkin K, Lopez E, Myer L, Paul RH, John S, Sunpath H.

BMC Res Notes. 2010 Jan 29;3:28. doi: 10.1186/1756-0500-3-28.

19.

Prolonged grief disorder: Psychometric validation of criteria proposed for DSM-V and ICD-11.

Prigerson HG, Horowitz MJ, Jacobs SC, Parkes CM, Aslan M, Goodkin K, Raphael B, Marwit SJ, Wortman C, Neimeyer RA, Bonanno GA, Block SD, Kissane D, Boelen P, Maercker A, Litz BT, Johnson JG, First MB, Maciejewski PK.

PLoS Med. 2009 Aug;6(8):e1000121. doi: 10.1371/journal.pmed.1000121. Epub 2009 Aug 4. Erratum in: PLoS Med. 2013 Dec;10(12). doi:10.1371/annotation/a1d91e0d-981f-4674-926c-0fbd2463b5ea. Bonanno, George [corrected to Bonanno, George A].

20.

Simplification of the research diagnosis of HIV-associated sensory neuropathy.

Evans SR, Clifford DB, Kitch DW, Goodkin K, Schifitto G, McArthur JC, Simpson DM.

HIV Clin Trials. 2008 Nov-Dec;9(6):434-9. doi: 10.1310/hct0906-434.

21.

Nutritional Contributions to the CNS Pathophysiology of HIV-1 Infection and Implications for Treatment.

Baldewicz TT, Brouwers P, Goodkin K, Kumar AM, Kumar M.

CNS Spectr. 2000 Apr;5(4):61-72.

PMID:
18277338
22.

Dementia and the Neurovirulence of HIV-1.

Shapshak P, Fujimura RK, Srivastava A, Goodkin K.

CNS Spectr. 2000 Apr;5(4):31-42.

PMID:
18277336
23.

HIV-1 Infection of the Nervous System Comes of Age.

Goodkin K.

CNS Spectr. 2000 Apr;5(4):27. No abstract available.

PMID:
18277335
24.

HIV-1 Infection, Neuroendocrine Abnormalities, and Clinical Outcomes.

Kumar M, Goodkin K, Kumar AM, Baldewicz TT, Morgan R, Eisdorfer C.

CNS Spectr. 2000 May;5(5):55-65.

PMID:
18268467
25.

Cognitive Effects of HIV-1 Infection.

Wilkie FL, Goodkin K, van Zuilen MH, Tyll MD, Lecusay R, Edwin T.

CNS Spectr. 2000 May;5(5):33-51.

PMID:
18268466
26.

Theory-Driven Interventions in Psychoneuroimmunology and HIV-1 Infection.

Tyll MD, Goodkin K, Blaney NT, Baldewicz TT, Hunt JD, Asthana D.

CNS Spectr. 2000 May;5(5):25-32.

PMID:
18268465
27.

Update on the Neuropsychiatric Aspects of HIV-1 Infection.

Goodkin K.

CNS Spectr. 2000 May;5(5):23. No abstract available.

PMID:
18268464
28.

HIV-1-Associated Cognitive-Motor Disorders: A Research-Based Approach to Diagnosis and Treatment.

Goodkin K, Wilkie FL, Baldewicz TT, Concha M, Tyl MD, Lopiccolo CJ, Shapshak P.

CNS Spectr. 2000 Aug;5(8):49-60.

PMID:
18192940
29.

Updated research nosology for HIV-associated neurocognitive disorders.

Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE.

Neurology. 2007 Oct 30;69(18):1789-99. Epub 2007 Oct 3.

30.

HIV-1 RNA concentration and cognitive performance in a cohort of HIV-positive people.

Vitiello B, Goodkin K, Ashtana D, Shapshak P, Atkinson JH, Heseltine PN, Eaton E, Heaton R, Lyman WD.

AIDS. 2007 Jul 11;21(11):1415-22.

PMID:
17589187
31.

Correlates of epidermal nerve fiber densities in HIV-associated distal sensory polyneuropathy.

Zhou L, Kitch DW, Evans SR, Hauer P, Raman S, Ebenezer GJ, Gerschenson M, Marra CM, Valcour V, Diaz-Arrastia R, Goodkin K, Millar L, Shriver S, Asmuth DM, Clifford DB, Simpson DM, McArthur JC; NARC and ACTG A5117 Study Group.

Neurology. 2007 Jun 12;68(24):2113-9.

PMID:
17562831
32.

Biochip array-based analysis of plasma cytokines in HIV patients with immunological and virological discordance.

Sachdeva N, Yoon HS, Oshima K, Garcia D, Goodkin K, Asthana D.

Scand J Immunol. 2007 Jun;65(6):549-54.

33.

Psychopharmacologic treatment response of HIV-infected patients to antipsychotic medications.

Singh D, Goodkin K.

J Clin Psychiatry. 2007 Apr;68(4):631-2. No abstract available.

PMID:
17474821
34.

Choice of antipsychotic in HIV-infected patients.

Singh D, Goodkin K.

J Clin Psychiatry. 2007 Mar;68(3):479-80. No abstract available.

PMID:
17388720
35.

Cerebrospinal and peripheral human immunodeficiency virus type 1 load in a multisite, randomized, double-blind, placebo-controlled trial of D-Ala1-peptide T-amide for HIV-1-associated cognitive-motor impairment.

Goodkin K, Vitiello B, Lyman WD, Asthana D, Atkinson JH, Heseltine PN, Molina R, Zheng W, Khamis I, Wilkie FL, Shapshak P.

J Neurovirol. 2006 Jun;12(3):178-89.

PMID:
16877299
36.

Regional quantitative comparison of multispliced to unspliced ratios of HIV-1 RNA copy number in infected human brain.

Fujimura RK, Khamis I, Shapshak P, Goodkin K.

J NeuroAIDS. 2004;2(4):45-60.

PMID:
16873205
37.

Evolution of neuro-AIDS during the HAART era.

Goodkin K.

J NeuroAIDS. 2002;2(3):1-17. No abstract available.

PMID:
16873196
38.

HIV neuropathy natural history cohort study: assessment measures and risk factors.

Simpson DM, Kitch D, Evans SR, McArthur JC, Asmuth DM, Cohen B, Goodkin K, Gerschenson M, So Y, Marra CM, Diaz-Arrastia R, Shriver S, Millar L, Clifford DB; ACTG A5117 Study Group.

Neurology. 2006 Jun 13;66(11):1679-87.

PMID:
16769940
39.

Impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals.

Clifford DB, Evans S, Yang Y, Acosta EP, Goodkin K, Tashima K, Simpson D, Dorfman D, Ribaudo H, Gulick RM.

Ann Intern Med. 2005 Nov 15;143(10):714-21.

PMID:
16287792
40.

Psychosocial factors and the course of cervical intra-epithelial neoplasia: a prospective study.

Tiersma ES, van der Lee ML, Garssen B, Peters AA, Visser AP, Fleuren GJ, van Leeuwen KM, le Cessie S, Goodkin K.

Gynecol Oncol. 2005 Jun;97(3):879-86.

PMID:
15894367
41.

HUMANS: An English and Spanish neuropsychological test battery for assessing HIV-1-infected individuals--initial report.

Wilkie FL, Goodkin K, Ardila A, Concha M, Lee D, Lecusay R, Suarez P, Van Zuilen MH, Molina R, O'Mellan S.

Appl Neuropsychol. 2004;11(3):121-33. Review.

PMID:
15590347
42.

Older age and plasma viral load in HIV-1 infection.

Goodkin K, Shapshak P, Asthana D, Zheng W, Concha M, Wilkie FL, Molina R, Lee D, Suarez P, Symes S, Khamis I.

AIDS. 2004 Jan 1;18 Suppl 1:S87-98.

PMID:
15075503
43.

Elevated expression of IFN-gamma in the HIV-1 infected brain.

Shapshak P, Duncan R, Minagar A, Rodriguez de la Vega P, Stewart RV, Goodkin K.

Front Biosci. 2004 May 1;9:1073-81.

PMID:
14977530
44.

Psychosocial factors and the grade of cervical intra-epithelial neoplasia: a semi-prospective study.

Tiersma ES, van der Lee ML, Peters AA, Visser AP, Jan Fleuren G, Garssen B, van Leeuwen KM, le Cessie S, Goodkin K.

Gynecol Oncol. 2004 Feb;92(2):603-10.

PMID:
14766254
45.

"Putting a face" on HIV infection/AIDS in older adults: a psychosocial context.

Goodkin K, Heckman T, Siegel K, Linsk N, Khamis I, Lee D, Lecusay R, Poindexter CC, Mason SJ, Suarez P, Eisdorfer C.

J Acquir Immune Defic Syndr. 2003 Jun 1;33 Suppl 2:S171-84. Review.

PMID:
12853867
46.

Cognitive functioning in younger and older HIV-1-infected adults.

Wilkie FL, Goodkin K, Khamis I, van Zuilen MH, Lee D, Lecusay R, Concha M, Symes S, Suarez P, Eisdorfer C.

J Acquir Immune Defic Syndr. 2003 Jun 1;33 Suppl 2:S93-S105.

PMID:
12853858
47.

Topotecan in the treatment of acquired immunodeficiency syndrome-related progressive multifocal leukoencephalopathy.

Royal W 3rd, Dupont B, McGuire D, Chang L, Goodkin K, Ernst T, Post MJ, Fish D, Pailloux G, Poncelet H, Concha M, Apuzzo L, Singer E.

J Neurovirol. 2003 Jun;9(3):411-9.

PMID:
12775425
48.

[HUMANS: a neuropsychological battery for evaluating HIV 1 infected patients].

Ardila-Ardila A, Goodkin K, Concha-Bartolini M, Lecusay-Ruiz R, O Mellan-Fajardo S, Suárez-Bustamante P, Molina-Vásquez R, Lee D, Chayeb G, Wilkie FL.

Rev Neurol. 2003 Apr 16-30;36(8):756-62. Spanish.

49.

Effects of a supportive-expressive group intervention on long-term psychosocial adjustment in HIV-infected gay men.

Weiss JJ, Mulder CL, Antoni MH, de Vroome EM, Garssen B, Goodkin K.

Psychother Psychosom. 2003 May-Jun;72(3):132-40.

PMID:
12707480
50.

Changes in health-related quality of life of men with prostate cancer 3 months after diagnosis: the role of psychosocial factors and comparisment with benign prostate hyperplasia patients.

Visser A, van Andel G, Willems P, Voogt E, Dijkstra A, Rovers P, Goodkin K, Kurth KH.

Patient Educ Couns. 2003 Mar;49(3):225-32.

PMID:
12642194

Supplemental Content

Loading ...
Support Center